ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Journal and News Scan

Source: European Journal of Cardio-Thoracic Surgery
Author(s): Rodrigo Modolo, Ply Chichareon, David van Klaveren, Ovidiu Dressler, Yiran Zhang, Joseph F Sabik, III, Yoshinobu Onuma, Arie Pieter Kappetein, Gregg W Stone, Patrick W Serruys

Modolo et al. present a substudy from the EXCEL trail. They looked into the impact of the SYNTAX score II treatment recommendation for patients with left main disease. Patients who were randomized to PCI treatment against the SYNTAX II CABG recommendation had a four-fold higher mortality compared to patients who underwent CABG in conclusion with the syntax II recommendation.

Source: Journal of the American College of Surgeons
Author(s): Vivek N. Prachand, Ross Milner, Peter Angelos, Mitchell C. Posner, John J. Fung, Nishant Agrawal, Valluvan Jeevanandam, Jeffrey B. Matthews

A prepublication manuscript describing a balanced system for multidimensional decision making about timing of surgery in the COVID era.

Source: JAMA Cardiology
Author(s): Anubodh S. Varshney, David D. Berg, Jason N. Katz, Vivian M. Baird-Zars, Erin A. Bohula, Anthony P. Carnicelli, Sunit-Preet Chaudhry, Jianping Guo, Patrick R. Lawler, Jose Nativi-Nicolau, Shashank S. Sinha, Jeffrey J. Teuteberg, Sean van Diepen, David A. Morrow, for the Critical Care Cardiology Trials Network Investigators

The UNOS donor heart allocation system was revised in 2018, giving priority to patients on inpatient mechanical circulatory support (MCS).  Patients admitted with heart failure-associated cardiogenic shock were tracked for the frequency of use of mechanical circulatory support before and after implementation of this change.   In non-transplant centers, there was no change in the frequency of MCS.  In transplant centers, use of MCS increased from 25% to 43%.

See also:  https://jamanetwork.com/journals/jamacardiology/article-abstract/2764755?resultClick=1

Source: The Annals of Thoracic Surgery
Author(s): Thoracic Surgery Outcomes Research Network, Inc: Mara Antonoff, Leah Backhus, Daniel J. Boffa, Stephen R. Broderick, Lisa M Brown, Phillip Carrot, James M. Clark, David Cooke, Elizabeth David, Matt Facktor, Farhood Farjah, Eric Grogan, James Isbell, David R. Jones, Biniam Kidane, Anthony W. Kim, Shaf Keshavjee, Seth Krantz, Natalie Lui, Linda Martin, Robert A. Meguid, Shari Meyerson, Tim Mullet, Heidi Nelson, David D. Odell, Joseph D. Phillips, Varun Puri, Valerie Rusch, Lawrence Shulman, Thomas K. Varghese, Elliot Wakeam, Douglas E. Wood

Guidance document for the triage of operations for thoracic malignancies produced by the Thoracic Outcomes Research Network. Their recommendations emphasize the importance of shared decision making, transparency and adherence to ethical principals. 

Source: The Annals of Thoracic Surgery
Author(s): Elizabeth H. Stephens, Joseph A. Dearani, Kristine J. Guleserian, David M. Overman, James S. Tweddell, Carl L. Backer, Jennifer C. Romano, Emile Bacha

Guidance document to assist in decision making and triage of congenital cardiac surgical patients during the COVID-19 pandemic. The article also includes guidance principles on the need and methods to preserve the workforce and emphasizes the need for regional collaboration, use of telecommunication technologies, and the evolving role of the congenital cardiac surgeon in the pandemic.  

Source: Canadian Journal of Cardiology
Author(s): Ansar Hassan, Rakesh C. Arora, Corey Adams, Denis Bouchard, Richard Cook, Derek Gunning, Yoan Lamarche, Tarek Malas, Michael Moon, Maral Ouzounian, Vivek Rao, Fraser Rubens, Philippe Tremblay, Richard Whitlock, Emmanuel Moss, Jean-François Légaré, on behalf of theCanadian Society of Cardiac Surgeons

Guidance Statement from the Canadian Society of Cardiac Surgeons (CSCS) and its Board of Directors on patient assessment and triage, risk reduction, and real-time sharing of expertise and experiences during the COVID-19 pandemic. 

Source: Financial Times
Author(s): Sarah Neville, Andrew Bounds, Mure Dickie, Federica Cocco, Bethan Staton

Topical review on the epidemic in Britain, with a number of observations that relate to the cardiothoracic surgeons and all healthcare professionals:

-The assertion that the National Health Service in Britain was overrun PRIOR to the pandemic.

-The assertion that acute angina is now being undertreated.

-Perhaps most worryingly, the assumed increase in non-COVID positive deaths in Scotland.

In the light of the government poised to review the lockdown in an attempt to balance the prevention of another viral infestation versus the conceivable grave financial implications here in the UK and worldwide, it is interesting to see their take on the financial toll on patients.

Source: The Annals of Thoracic Surgery
Author(s): Olga N. Kislitsina, James D. Thomas, Erin Crawford, Eriberto Michel, Jane Kruse, Menghan Liu, Adin-Cristian Andrei, James L. Cox, Patrick M. McCarthy

Prediction of postoperative ventricular dysfunction is performed using preop LVEF prior to mitral valve surgery for degenerative mitral regurgitation. In this study the utility of LV strain as a predictor of ventricular dysfunction after mitral surgery was assessed. Preoperative RV, LV, and LA strain were strongly associated with postoperative LV dysfunction, and may prove useful in timing of surgery for degenerative mitral regurgitation.

Source: European Journal of Cardio-Thoracic Surgery
Author(s): Moritz von Scheidt, Dario Bongiovanni, Ulrich Tebbe, Bernd Nowak, Jan Stritzke, Qiang Zhao, Yunpeng Zhu, Adnan Kastrati, Salvatore Cassese, Heribert Schunkert

The authors present a meta-analysis of randomized controlled trials regarding the outcome of ticagrelor-based antiplatelet therapies in patients after coronary artery bypass graft (CABG) surgery. They found a reduced rate of major adverse cardiac events and a reduced mortality in these patients receiving aspirin and/or clopidogrel. This finding should be investigated in randomized trials, as it could potentially change the standard of care of CABG patients.

Source: The Annals of Thoracic Surgery
Author(s): Jonathan D. Rice, Justin Heidel, Jaimin R. Trivedi, Victor H. van Berkel

The NCDB was queried to assess the optimal timing for resection after induction therapy for IIIA NSCLC.  Survival was better in patients who underwent surgery in a short delay interval (<77 days) compared to a long delay (>114 days); short and medium delay intervals had similar outcomes.  

Pages